Jesús María
Hernández Rivas
Catedrático de Universidad
![Foto de Jesús María](/img/uploaded/22eccb650f0a1f4a59fe4629ca87e13e.jpg)
![Foto de Hospital Regional Universitario de Málaga](/img/noimage_org.png)
Hospital Regional Universitario de Málaga
Málaga, EspañaHospital Regional Universitario de Málaga-ko ikertzaileekin lankidetzan egindako argitalpenak (12)
2020
-
Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-15
2019
2018
-
Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 1, pp. 146-154
2017
-
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid
Annals of hematology, Vol. 96, Núm. 7, pp. 1069-1075
2016
2014
-
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols
Cancer, Vol. 120, Núm. 24, pp. 3958-3964
2012
-
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation
British Journal of Haematology, Vol. 159, Núm. 1, pp. 78-81
2010
-
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA study group
Haematologica, Vol. 95, Núm. 4, pp. 589-596
2007
-
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia
European Journal of Haematology, Vol. 78, Núm. 2, pp. 102-110